Sophiris Bio's common stock is $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Sophiris Bio (SPHS) currently reports a common stock of $0 as of September 2019. In the prior-year period, the figure was $0. Use the charts on this page to explore Sophiris Bio's common stock history and peer comparisons.
Sophiris Bio's common stock changed from $0 to $0 (period ending September 2019). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Sophiris Bio reported $0 in common stock as of September 2019. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sophiris Bio, and consider following SPHS for alerts when major investors trade the stock.
Sophiris Bio is classified in the Healthcare sector. On common stock, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SPHS with unrelated industries.